Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 901–1,000 of 1,004
S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts
Bostner, J., Karlsson, E. A., Bivik, C. A., Pérez‐Tenorio, G., Franzén, H., Konstantinell, A., Fornander, T., Nordenskjöld, B. A., & Stål, O. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0513 · Cited by 33
Wang, J., Zhong, C., Wang, F., Qu, F., & Ding, J. (2013) · Biochemical Journal · doi:10.1042/bj20121863 · Cited by 36
den Hartigh, L. J., Goodspeed, L., Wang, S. A., Kenerson, H. L., Omer, M., O’Brien, K. D., Ladiges, W., Yeung, R. S. W., & Subramanian, S. (2018) · Experimental Physiology · doi:10.1113/ep087207 · Cited by 34
“…as has been demonstrated in other published studies and, in fact, led to modest improvements in bodyweight, triglycerides and glucosemetabolism. mTORC1 is highly activated in insulin-sensitive tissues of obese and high-fat-fed rodents (Khamzina et al., 2005; Tremblay et al., 2005; Um et al., 2004).”
InfluentialAttenuation of Free Fatty Acid-Induced Muscle Insulin Resistance by Rosemary Extract
Vlavcheski, F., & Tsiani, E. (2018) · Nutrients · doi:10.3390/nu10111623 · Cited by 36
“The present study found increased serine phosphorylation of IRS-1, and increased phosphorylation of mTOR, p70 S6K and JNK by palmitate and an effect of RE treatment to inhibit them and restore the insulin-stimulated Akt phosphorylation and the insulin-stimulated glucose uptake.”
BackgroundResultInfluentialXu, X., Keshwani, M. M., Meyer, K. R., Sarikas, A., Taylor, S. S., & Pan, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405209 · Cited by 34
“In further support of the role of the mTORC1/S6K1-IRS1 feedback loop in the pathogenesis of type 2 diabetes, S6K1-deficient mice displayed enhanced insulin sensitivity when chronically maintained on a high fat diet (7).”
BackgroundmTOR tells the brain that the body is hungry
Kahn, B. B., & Myers, M. G. (2006) · Nature Medicine · doi:10.1038/nm0606-615 · Cited by 36
Burke, B. I., Ismaeel, A., Long, D. E., Depa, L. A., Coburn, P. T., Goh, J. Z., Saliu, T. P., Walton, B. J., Vechetti, I. J., Peck, B. D., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182589 · Cited by 33
Insulin Signaling: Inositol Phosphates Get into the Akt
Manning, B. D. (2010) · Cell · doi:10.1016/j.cell.2010.11.040 · Cited by 30
Regulation of Metabolic Disease-Associated Inflammation by Nutrient Sensors
Yamashita, A. S., Belchior, T., Lira, F. S., BISHOP, N. C., Wessner, B., Neto, J. C. R., & Festuccia, W. T. (2018) · Mediators of Inflammation · doi:10.1155/2018/8261432 · Cited by 35
“Importantly, mTORC1 is overactivated in adipose tissue, liver, and skeletal muscle of diet- and geneticinduced obese, insulin-resistant rodents [87, 88].”
BackgroundHartogh, D. J. D., Vlavcheski, F., Giacca, A., MacPherson, R. E. K., & Tsiani, E. (2022) · Cells · doi:10.3390/cells11010167 · Cited by 33
Moon, J. Y., Kim, H., & Cho, S. K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/402385 · Cited by 32
Wang, X. J., Wei, D. L., Song, Z., Jiao, H., & Lin, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036663 · Cited by 36
“Recent evidence demonstrates that muscle mTOR is overactivated in obese rodents, high-fat-fed rodents and in vitro L6 myotubes exposed to PA [19,68,69], and S6K1-null mice are protected from high fat diet-induced adverse effects [50].”
BackgroundMao, J., Luo, H., Han, B., Bertrand, R., & Wu, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802255 · Cited by 35
“This result seems to be in conflict with our findings that rapamycin protected cells from apoptosis, and previous reports showing that p70S6 kinase gene knockout leads to increased insulin sensitivity (22) and that overactivation of mTOR/p70S6 kinase is responsible for impaired insulin action (23).”
ResultMammalian target of rapamycin complex 1 (mTORC1) signaling in energy balance and obesity
Cota, D. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.03.006 · Cited by 38
Egr1 mediates the effect of insulin on leptin transcription in adipocytes
Mohtar, O., Ozdemir, C., Roy, D., Shantaram, D., Emili, A., & Kandror, K. V. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.007855 · Cited by 34
Li, S., Fang, C. X., Aberle, N. S., Ren, B. H., Ceylan‐Isik, A. F., & Ren, J. T. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06168 · Cited by 32
“Last but not least, mice deficient for p70s6k (S6K1), an effector of Akt/mTOR, were shown to be hypoinsulinaemic, glucose intolerant and protected against age- and diet-induced obesity with enhanced insulin sensitivity (Um et al. 2004).”
BackgroundKoketsu, Y., Sakoda, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., Ono, H., Anai, M., Kikuchi, T., Fukuda, T., Kamata, H., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2007 · Cited by 33
“Meanwhile, in genetic models of obesity, such as K/KAy and ob/ob mice, insulin signaling is suppressed with increased phosphorylation of Ser(307) and Ser in IRS-1 (26).”
BackgroundInfluentialThe Proton-Coupled Monocarboxylate Transporter Hermes Is Necessary for Autophagy during Cell Death
Velentzas, P. D., Zhang, L., Das, G., Chang, T.-K., Nelson, C., Kobertz, W. R., & Baehrecke, E. H. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.015 · Cited by 31
“mTOR signaling is a key nutrient sensing pathway, and increased activation of mTOR has been linked to insulin resistance and type 2 diabetes (Polak et al., 2008; Um et al., 2004).”
BackgroundRibosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
“Underlying mechanisms include beneficial long-term effects on glucose homeostasis, adipose tissue biology and effects upon key hormone and energy sensing signalling pathways 9, 12, 13, 17 .”
BackgroundRibosomal S6 kinase 1 regulates inflammaging via the senescence secretome
(2024) · doi:10.1038/s43587-024-00695-z · Cited by 31
Chen, C., Du, Y., Yamaguchi, H., Hsu, J.-M., Kuo, H.-P., Hortobágyi, G. N., & Hung, M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0180 · Cited by 33
“D12492) (24) or a normal chow diet (ND) (Teklad Global Diets, #2919) (Supplementary Table 1) starting at 4 weeks of age.”
BackgroundCaccamo, A., Belfiore, R., & Oddo, S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.032 · Cited by 30
“These apparent paradoxical events are linked to a negative feedback loop in which hyperactive S6K1 phosphorylates the insulin receptor substrate-1 (IRS-1), thereby leading to the internalization of the receptor and insulin resistance (Um et al., 2004).”
RetractedCrombie, E. M., Kim, S., Adamson, S. S., Dong, H., Lu, T., Wu, Y., Wu, Y., Levy, Y., Stimple, N., Lam, W. M. R., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13121 · Cited by 31
Rohrbach, S., Aslam, M., Niemann, B., & Schulz, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12650 · Cited by 38
“Moreover, deletion of mTORC1 substrate S6K1 (ribosomal S6 kinase) is sufficient to confer increased lifespan in mice (Selman et al., 2009) and mice lacking S6K1 are protected from obesity and metabolic disorders (Um et al., 2004).”
BackgroundKaibori, M., Shikata, N., Sakaguchi, T., Ishizaki, M., Matsui, K., Iida, H., Tanaka, Y., Miki, H., Nakatake, R., Okumura, T., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3417-7 · Cited by 33
“Further, mTORC1 inhibits the activation ofmTORC2 by phosphorylating and stabilizingGrb10 [37, 38] and inhibits the phosphorylation of IRS-1 by S6K1 [39], which inhibits growth-factor signaling.”
BackgroundThe mammalian target of rapamycin pathway and its role in molecular nutrition regulation
Lian, J., Yan, X., Peng, J., & Jiang, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700005 · Cited by 37
Sam68 Regulates S6K1 Alternative Splicing during Adipogenesis
Song, J., & Richard, S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01488-14 · Cited by 33
“S6K1 / mice have decreased adipose tissue mass, increased energy expenditure, and are resistant to dietary-induced obesity (40).”
BackgroundRobinson, K. A., & Buse, M. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2007 · Cited by 34
Glutamate Transporter-Dependent mTOR Phosphorylation in Müller Glia Cells
López-Colomé, A. M., Martínez‐Lozada, Z., Guillem, A. M., López, E., & Ortega, A. (2012) · ASN NEURO · doi:10.1042/an20120022 · Cited by 33
“The return of mTOR phosphorylation to basal levels in both conditions suggests a Glu- or D-Asp-dependent p70 dephosphorylation that through a feedback loop would decrease mTOR Ser-2448 phosphorylation (Harrington et al., 2004; Um et al., 2004; Rosner and Hengstschlager, 2010).”
BackgroundResveratrol Inhibition of Cellular Respiration: New Paradigm for an Old Mechanism
Pérez, L. A. M., & Ramos‐Gómez, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030368 · Cited by 33
“The absence of the S6K1 protein in mice protected them against obesity, enhanced β-oxidation, and improved insulin sensitivity, whereas two genetic models of obesity (mice K/KAy and ob/ob) fed with a high-fat diet showed markedly elevated S6K1 activity [58].”
BackgroundDifferent interactomes for p70‐S6K1 and p54‐S6K2 revealed by proteomic analysis
Pavan, I. C. B., Yokoo, S., Granato, D. C., Meneguello, L., Carnielli, C. M., Tavares, M. R., do Amaral, C. L., Freitas, L., Leme, A. F. P., Luchessi, A. D., et al. (2016) · PROTEOMICS · doi:10.1002/pmic.201500249 · Cited by 34
“Finally, studies have shown that S6K2 knockout in mice leads to larger animals in comparison to smaller animals generated by S6K1 knockout [1, 10, 32].”
BackgroundObesity: Genomics and Postgenomics
Capel, F. (2007) · CRC Press eBooks · doi:10.3109/9781420020137 · Cited by 34
Dysregulation of the mTOR pathway in p53-deficient mice
Leontieva, O. V., Novototskaya, L. R., Paszkiewicz, G., Komarova, E. A., Gudkov, A. V., & Blagosklonny, M. V. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26947 · Cited by 33
“Also, activated mTOR can cause insulin resistance by feedback inhibition of insulin signaling.(76,77) In fact, basal levels of fasting insulin were increased in p53 mice, consistent with resistance to insulin, given that levels of glucose were unchanged.”
BackgroundLivers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt
Kenerson, H. L., Subramanian, S., McIntyre, R., Kazami, M., & Yeung, R. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117000 · Cited by 31
mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases
Sandoval, M. C., Heberle, A. M., Rehbein, U., Barile, C., Pittol, J. M. R., & Thedieck, K. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.761333 · Cited by 33
Balram, A., Thapa, S., & Chatterjee, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315442 · Cited by 34
Kakoty, V., Sarathlal, K. C., Kumari, S., Yang, C., Dubey, S. K., Sahebkar, A., Kesharwani, P., & Taliyan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01187-z · Cited by 36
Shin, S., Han, M.-J., Jedrychowski, M. P., Zhang, Z., Shokat, K. M., Plas, D. R., Dephoure, N., & Yoon, S.-O. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112868 · Cited by 33
Extract from Dioscorea batatas Ameliorates Insulin Resistance in Mice Fed a High-Fat Diet
Kim, S., Jwa, H., Yanagawa, Y., & Park, T. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2011.2008 · Cited by 33
“Several studies reported that S6K1 and ERK phosphorylations were highly elevated in animals fed a HFD, whereas AKT activity was blunted in adipose tissue.(10,40) In DB extract-treated mice, p-ERK and p-S6K1 protein expressions were down-regulated, whereas p-AKT protein expression was up-regulated compared with that in…”
Vatner, S. F., Pachon, R. E., & Vatner, D. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/250310 · Cited by 33
“Igf-1r+/− KO [10, 50, 51] S6K1−/− KO [52, 53]”
Quantification of the effect of amino acids on an integrated mTOR and insulinsignaling pathway
Vinod, P. K. U., & Venkatesh, K. V. (2009) · Molecular BioSystems · doi:10.1039/b816965a · Cited by 30
The role of endoplasmic reticulum stress in hippocampal insulin resistance
Sims‐Robinson, C., Bakeman, A., Glasser, R., Boggs, J. M., Pacut, C. M., & Feldman, E. L. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.007 · Cited by 32
“The serine phosphorylation of IRS1 reduces the ability of IRS proteins to attract PI 3-kinase, thereby decreasing its activation and downstream insulin signaling (Aguirre et al., 2002; Birnbaum, 2001; Patti and Kahn, 2004; Qiao et al., 1999; Qiao et al., 2002; Um et al., 2004; White, 2003).”
BackgroundXu, X., Sun, J. F., Song, R., Doscas, M. E., Williamson, A. J., Zhou, J., Sun, J., Jiao, X., Liu, X., & Li, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16737 · Cited by 30
“S6K1 depletion mimics the effect of diet restriction [9, 10].”
Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D)
Ali, M. Z., Bukhari, S. A., Ali, M. Z., & Lee, H.-W. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.12.206 · Cited by 32
Sexual dimorphism in insulin resistance in a metabolic syndrome rat model
Velasco, M., Ortiz-Huidobro, R. I., Larqué, C., Sánchez-Zamora, Y. I., Romo‐Yáñez, J., & Hiriart, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0288 · Cited by 35
“A well-documented mechanism suggests that mTOR and its downstream target, the ribosomal protein S6 kinase 1(S6K1 or P70S6K1) participates in the obesity-induced IR (21, 43-46), since S6K1 deficient mice (S6K1-/-) were protected from diet-induced IR (46).”
BackgroundPotential Role of the AMP-activated Protein Kinase in Regulation of Insulin Action.
Fisher, J. S. (2006) · PubMed · Cited by 34
Kaeberlein, M., & Kennedy, B. K. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00439.x · Cited by 30
“In addition, S6 kinase phosphorylates insulin receptor substrate 1 (IRS1) and dampens insulin signaling (Um et al., 2004).”
BackgroundGrowth or longevity: the TOR’s decision on lifespan regulation
Wei, Y., Zhang, Y., & Cai, Y. (2013) · Biogerontology · doi:10.1007/s10522-013-9435-6 · Cited by 32
Hwang, S., Li, X., Lee, J.-Y., & Chang, H. W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.038 · Cited by 29
Cavanaugh, A. R., Schwartz, G. J., & Blouet, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118888 · Cited by 29
“Increased baseline mTORC1 activity as a consequence of HF feeding has been consistently reported in several tissues including the liver, adipose tissue, muscle and hippocampus [25–27], but this result contrasts with a study reporting that HF feeding reduced mTORC1 signaling in the hypothalamus [28].”
ResultLee, S. J., Kim, J. Y., Nogueiras, R., Linares, J. F., Pérez–Tilve, D., Jung, D. Y., Ko, H. J., Hofmann, S. M., Drew, A. F., Leitges, M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.003 · Cited by 31
“Several of the signaling molecules that have been implicated in the pathophysiology of obesity were primarily known for their roles in the control of cell growth, differentiation, and apoptosis (Fajas et al., 2002; Flier, 2004; Hirosumi et al., 2002; Kim et al., 2004b; Matsumoto et al., 2003; Molero et al., 2004; Naka…”
Amino acid-induced impairment of insulin sensitivity in healthy and obese rats is reversible
Jeganathan, S., Abdullahi, A., Zargar, S., Maeda, N., Riddell, M. C., & Adegoke, O. A. J. (2014) · Physiological Reports · doi:10.14814/phy2.12067 · Cited by 32
“Indeed mice that lack S6K1 are protected against dietinduced insulin resistance (Um et al. 2004).”
BackgroundReview of Novel Aspects of the Regulation of Ghrelin Secretion
Al–Massadi, O., Lear, P., Müller, T. D., López, M., Diéguez, C., Tschöp, M. H., & Nogueiras, R. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140505153723 · Cited by 32
Shamshoum, H., Vlavcheski, F., MacPherson, R. E. K., & Tsiani, E. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0592 · Cited by 32
The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt
Tooley, A. S., Kazyken, D., Bodur, Ç., Gonzalez, I. E., & Fingar, D. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100942 · Cited by 31
“Moreover, treatment of obese mice or human patients with amlexanox, or knockout of TBK1, Raptor (mTORC1 partner protein), or S6K1 (mTORC1 substrate) in mouse adipocytes, reduces adiposity and body mass, in part due to increased energy expenditure (50, 52, 54, 59).”
BackgroundBlocking MG53 S255 Phosphorylation Protects Diabetic Heart From Ischemic Injury
Lv, F., Wang, Y., Shan, D., Guo, S., Chen, G., Jin, L., Zheng, W., Feng, H., Zeng, X., Zhang, S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321055 · Cited by 32
Sanz‐Castillo, B., Hurtado, B., Vara‐Ciruelos, D., Bakkali, A. E., Hermida, D., Salvador-Barberó, B., Martínez‐Alonso, D., González‐Martínez, J., Santiveri, C. M., Campos‐Olivas, R., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022110833 · Cited by 32
4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL
Singh, M., Shin, Y., Yang, X., Zehr, B., Chakrabarti, P., & Kandror, K. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631895 · Cited by 30
The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling
Sully, K., Akinduro, O., Philpott, M. P., Naeem, A. S., Harwood, C. A., Reeve, V. E., O’Shaughnessy, R. F. L., & Byrne, C. R. (2012) · Oncogene · doi:10.1038/onc.2012.338 · Cited by 32
Cardiac Insulin Resistance and MicroRNA Modulators
Pulakat, L., Aroor, A. R., Gul, R., & Sowers, J. R. (2011) · Experimental Diabetes Research · doi:10.1155/2012/654904 · Cited by 30
“Mice deficient in S6K1, though they have a small body size and reduced β-cell mass, are protected from INS resistance in conditions of overnutrition [94].”
BackgroundWang, Q., He, G., Mai, K., Xu, W., Zhou, H., Wang, X., & Mei, L. (2016) · Scientific Reports · doi:10.1038/srep28068 · Cited by 31
Uzhachenko, R. V., Boyd, K. L., Olivares–Villagómez, D., Zhu, Y., Goodwin, J. S., Rana, T., Shanker, A., Tan, W. J. T., Bondar, T., Medzhitov, R. M., et al. (2017) · Aging · doi:10.18632/aging.101213 · Cited by 31
mTOR Signaling as a Target of Amino Acid Treatment of the Age-Related Sarcopenia
D’Antona, G., & Nisoli, E. (2010) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000319998 · Cited by 35
Obesity Notches up fatty liver
Czech, M. (2013) · Nature Medicine · doi:10.1038/nm.3293 · Cited by 33
Therapeutic potential of dithiolethiones for hepatic diseases
Brooks, S. C., Brooks, J. S., Lee, W. H., Lee, M. G., & Kim, S. G. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.006 · Cited by 30
“Thus, this negative feedback loop causes metabolic disorders including insulin resistance because of IRS1 down-regulation (Um et al., 2004).”
BackgroundMitochondria in response to nutrients and nutrient-sensitive pathways
Baltzer, C., Tiefenböck, S. K., & Frei, C. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.07.009 · Cited by 34
“Indeed, S6K null animals are lean and protected against diet-induced obesity (Um et al., 2004).”
BackgroundBuse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 51
Aziz, A. U. R., Farid, S., Qin, K., Wang, H., & Liu, B. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1498903 · Cited by 28
Okuno, K., Cicalese, S. M., Elliott, K. J., Kawai, T., Hashimoto, T. N., & Eguchi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186579 · Cited by 29
“Interestingly, S6KI deficient mice is protected against age or diet-induced obesity while enhancing insulin sensitivity [95], have extended life span and recapitulate the phenotype seen with caloric restriction or pharmacological AMPK activation [96].”
BackgroundNew Insights in the Control of Fat Homeostasis: The Role of Neurotensin
Barchetta, I., Baroni, M. G., Melander, O., & Cavallo, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042209 · Cited by 31
“FXR overexpression and mimic peptides ameliorate glucose tolerance, insulin sensitivity, and lipid profile in experimental models [74,75].”
BackgroundS6 kinase 1 at the central node of cell size and ageing
Fumagalli, S., & Pende, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.949196 · Cited by 31
“Consistently, the increase in insulin sensitivity of S6K1-deficient mice correlates with a decrease in IRS1 Ser/Thr phosphorylation (Um et al., 2004).”
BackgroundSelf-citationA molecular rheostat at the interface of cancer and diabetes
Osman, M. A., Sarkar, F. H., & Rodriguez-Boulan, E. J. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.005 · Cited by 31
“By contrast, other studies reported that constitutive activity of S6K1 in mice led to increased insulin secretion without increasing β-cell mass [44], and that loss of S6K improved insulin-sensitivity and protected against diet-induced obesity [37].”
BackgroundResultHurtado-Carneiro, V., Roncero, I., Egger, S. S., Wenger, R. H., Blázquez, E., Sanz, C., & Álvarez, E. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8630-4 · Cited by 33
Hou, T. Y., Ward, S. M., Murad, J., Watson, N. P., Israel, M. A., & Duffield, G. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013961 · Cited by 28
Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways
Malla, R., Wang, Y., Chan, W. K., Tiwari, A. K., & Faridi, J. S. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.016 · Cited by 28
Watanabe, M., Hisatake, M., & Fujimori, K. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00821 · Cited by 29
Self-citationEffects of free fatty acids on carbohydrate metabolism and insulin signalling in perfused rat liver
Anderwald, C. H., Brunmair, B., Stadlbauer, K., Krebs, M., Fürnsinn, C., & Roden, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01858.x · Cited by 29
The mTOR pathway in Gliomas: From molecular insights to targeted therapies
Pournajaf, S., & Pourgholami, M. H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118237 · Cited by 28
Guo, T., Dakkak, D., Rodríguez-Martín, T., Noble, W. J., & Hanger, D. P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0651-9 · Cited by 28
Zhu, Y., Li, X., Liu, J., Zhou, G., Yu, Y., Li, J., Shi, Z., Zhou, X., & Sun, Z. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.02.003 · Cited by 27
Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications
Yang, L., Zhang, Z., Wang, D., Jiang, Y., & Liu, Y. (2022) · Current Drug Targets · doi:10.2174/1389450123666220111115528 · Cited by 29
Mediobasal hypothalamic FKBP51 acts as a molecular switch linking autophagy to whole-body metabolism
Häusl, A. S., Bajaj, T., Brix, L. M., Pöhlmann, M. L., Hafner, K., Angelis, M. D., Nagler, J., Dethloff, F., Balsevich, G., Schramm, K., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi4797 · Cited by 27
Development of Organometallic S6K1 Inhibitors
Qin, J., Rajaratnam, R., Li, F., Salami, J., Barber-Rotenberg, J. S., Domsic, J. F., Reyes-Uribe, P. I., Liu, H., Dang, W., Berger, S. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5011868 · Cited by 29
Kim, M. K., Yang, S., Lee, K. H., Um, J., Liu, M., Kang, H., Park, S. J., & Chung, J. H. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00092.2011 · Cited by 30
“S6K1 / mice are resistant to age- and diet-induced obesity and insulin resistance, have reduced adipose tissue mass, and have increased energy expenditure and lipolysis (12, 25, 66, 68).”
Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart
Klement, G. L., Goukassian, D. A., Hlatky, L., Carrozza, J. P., Morgan, J. P., & Yan, X. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00113 · Cited by 28
Stefater, M. A., & Seeley, R. J. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104723 · Cited by 28
Barrows, D., Schoenfeld, S., Hodakoski, C., Silkov, A., Honig, B. H., Couvillon, A. D., Shymanets, A., Nürnberg, B., Asara, J. M., & Parsons, R. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668244 · Cited by 28
“been identified previously, including mTORC1-dependent ribosomal S6 kinase phosphorylation of IRS1 (78, 79).”
BackgroundInsulin receptor substrate 1 is a substrate of the Pim protein kinases
Song, J. H., Padi, S. K. R., Luevano, L. A., Minden, M. D., DeAngelo, D. J., Hardiman, G., Ball, L. E., Warfel, N. A., & Kraft, A. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7918 · Cited by 27
“p70S6K has been shown to phosphorylate serine residues on IRS1, including S307 [33, 34], S312, S616, S636/S639 [35] and S1101 [32].”
BackgroundChen, J., Sun, J. F., Prinz, R. A., Li, Y., & Xu, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800709 · Cited by 27
Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis
Xie, J., Shen, K., Jones, A. T., Yang, J., Tee, A. R., Shen, M. H., Yu, M., Irani, S., Wong, D., Merrett, J. E., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03491-1 · Cited by 30
“As expected, IGF-1 increased the phosphorylation of S6K1, rpS6, 4E-BP1 and PKB/Akt (on Ser473, an mTORC2 site) (Fig.”
BackgroundInfluentialThe Nuclear Receptor DHR3 Modulates dS6 Kinase–Dependent Growth in Drosophila
Montagne, J., Lecerf, C., Parvy, J.-P., Callister, J. B., Radimerski, T., Ruhf, M.-L., Zilbermann, F., Vouilloz, N., Stocker, H., Hafen, E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000937 · Cited by 31
“Interestingly, it was recently reported that RORa-deficient mice, like S6K1deficient mice [69], exhibit reduced fat-pad mass, smaller adipocytes, and resistance to diet-induced obesity [70].”
BackgroundSelf-citationLi, G., Lin, L., Wang, Y., & Yang, H. (2019) · Reproductive Sciences · doi:10.1177/1933719118766253 · Cited by 30
“In S6K1 knockout or rapamycin-treated mice, inhibition of mTORC1 increased lipolysis in adipose tissues.(49,50) The mTOR signaling pathway is critical in cell apoptosis and proliferation and affects nutrient metabolism.”
BackgroundResistance exercise and skeletal muscle: protein synthesis, degradation, and controversies
Ji, F., Lee, H. S., & Kim, J.-H. (2025) · European Journal of Applied Physiology · doi:10.1007/s00421-025-05832-z · Cited by 31
“While the precise mechanisms remain unclear, S6K1 upregulation amplifies its inhibitory feed-back on IRS-1, impairing PI3K and AKT activation (Adams 1998; Harrington et al. 2004; Um et al. 2004).”
Kong, L. D., Sun, Y., Sun, H. J., Zhang, A., Zhang, B., Ge, N., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.728256 · Cited by 29
“S6K1 absence leads to hypoinsulinemia, glucose intolerance, and β-cell disorder (Um et al., 2004).”
BackgroundNormalizing a hyperactive mTOR initiates muscle growth during obesity
Williamson, D. L., & Drake, J. C. (2011) · Aging · doi:10.18632/aging.100290 · Cited by 26
“Despite hyperactivation of the growth-promoting, nutrient-sensing mTOR pathway, atrophy persists in obese muscle [7].”
BackgroundS6K1 controls pancreatic β cell size independently of intrauterine growth restriction
Um, S. H., Sticker-Jantscheff, M., Chau, G. C., Vintersten, K., Mueller, M., Gangloff, Y., Adams, R. H., Spetz, J.-F., Elghazi, L., Pfluger, P. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77030 · Cited by 27
“As noted above, this stems from the fact that S6K1-deficient mice are hypoinsulinemic, a phenotype which we found was not associated with the transcription, synthesis, degradation, or intrinsic secretion of insulin, but with diminished β cell size (9, 14).”
InfluentialSelf-citationPhosphorylation of IRS1 at serine 307 and serine 312 in response to insulin in human adipocytes
Danielsson, A., Nyström, F. H., & Strålfors, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.075 · Cited by 26
Sun, X., Hayashi, Y., Xu, S., Kanou, Y., Takagishi, Y., Tang, Y., & Murata, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014605 · Cited by 34
“Rps6kb1 mice appear to be protected against obesity due to the up-regulation of genes such as uncoupling protein 1 (Ucp1), Ucp3, Ppar-c co-activator-a (Pgc1-a) and peroxisome proliferatoractivated receptor b/d (Ppar-b/d) that control the oxidative phosphorylation pathway [16].”
BackgroundZolotnik, I. A., Figueroa, T. Y., & Yaspelkis, B. B. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.038 · Cited by 27
“Activated IKKβ has been shown to directly phosphorylate IRS-1 on serine 307 (Gao et al., 2002), and increased IRS-1 serine phosphorylation leads to decreased PI3-K activation and inhibition of the insulin signaling cascade (Hirosumi et al., 2002; Kim et al., 2004; Um et al., 2004; Yu et al., 2002).”
BackgroundJózefczuk, J., Kashofer, K., Ummanni, R., Henjes, F., Rehman, S., Geenen, S., Wruck, W., Regenbrecht, C. R. A., Daskalaki, A., Wierling, C., et al. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00339 · Cited by 30
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.